Q-linea AB (CHIX:QLINES) Other Stockholders Equity: kr2,033.97 Mil (As of Mar. 2026)


CHIX:QLINES Q-linea AB CHIX:QLINES
68 GF Score
Price kr1,610.00
GF Value kr1,981.69
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Other Stockholders Equity?

Q-linea AB CHIX:QLINES 68 Other Stockholders Equity is kr2,033.97 Mil as of Mar. 2026. GuruFocus rates CHIX:QLINES with a GF Score™ of 68/100 and a GF Value™ of kr1,981.69. The stock has 3 warning signs investors should review.

Q-linea AB's Other Stockholders Equity for the quarter that ended in Mar. 2026 was kr2,033.97 Mil.

Q-linea AB's quarterly Other Stockholders Equity declined from Sep. 2025 (kr1,738.15 Mil) to Dec. 2025 (kr-7.87 Mil) but then increased from Dec. 2025 (kr-7.87 Mil) to Mar. 2026 (kr2,033.97 Mil).

Q-linea AB's annual Other Stockholders Equity increased from Dec. 2023 (kr-0.74 Mil) to Dec. 2024 (kr1.31 Mil) but then declined from Dec. 2024 (kr1.31 Mil) to Dec. 2025 (kr-7.87 Mil).

Q-linea AB Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Other Stockholders Equity Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.14 -0.00 -0.74 1.31 -7.87

Q-linea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.58 1,674.62 1,738.15 -7.87 2,033.97
CHIX:QLINES
68GF Score
Q-linea AB CHIX:QLINES
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-linea AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of kr2,033.97 Mil mean?
Q-linea AB (CHIX:QLINES) has a Other Stockholders Equity of kr2,033.97 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Q-linea AB and its competitors.
Is Q-linea AB's Other Stockholders Equity too high?
Q-linea AB's current Other Stockholders Equity is kr2,033.97 Mil. Overall, Q-linea AB has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Other Stockholders Equity compare to ABT and SYK?
Q-linea AB's Other Stockholders Equity of kr2,033.97 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Q-linea AB and its competitors. Q-linea AB's current Other Stockholders Equity is kr2,033.97 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Q-linea AB (CHIX:QLINES) has a current Other Stockholders Equity of kr2,033.97 Mil. The stock's GF Value™ is kr1,981.69, compared to a current price of kr1,610.00 — trading 18.8% below its estimated fair value. The current Other Stockholders Equity is kr2,033.97 Mil. Q-linea AB's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Q-linea AB (CHIX:QLINES), the current Other Stockholders Equity is kr2,033.97 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (CHIX:QLINES) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr1,610.00 is trading 18.8% below its estimated GF Value™ of kr1,981.69.

Key valuation signals for CHIX:QLINES:

  • Other Stockholders Equity: kr2,033.97 Mil
  • GF Value™: kr1,981.69 vs. price of kr1,610.00 (18.8% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the CHIX:QLINES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Q-linea AB Business Description

Other Exchanges QLINEA:Sweden3F80:Germany
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
68GF Score

Get the complete analysis for CHIX:QLINES

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1,610.00
Price
kr1,981.69
GF Value